Get the latest Science News and Discoveries

Doctors stunned by a cheap drug’s power against colon cancer


A Scandinavian clinical trial has revealed that low-dose aspirin can halve the risk of colon and rectal cancer recurrence in patients with specific genetic mutations. The research, involving over 3,500 patients, is the first randomized study to confirm aspirin’s powerful effect in this context. The findings suggest aspirin could become a widely available, inexpensive precision medicine, reshaping cancer treatment strategies globally.

None

Get the Android app

Or read this on ScienceDaily

Read more on:

Photo of power

power

Photo of Doctors

Doctors

Photo of Colon cancer

Colon cancer

Related news:

News photo

Passive silver-nanoring coating points to “self-regulating” smart windows — without power or tinting - EurekAlert!

News photo

New AI Tool Finds Hidden Brain Lesions That Doctors Miss in Children With Epilepsy

News photo

Doctors and nurses are better than AI at triaging patients - EurekAlert!